Syner-G Acquires Impact Pharmaceutical Services

Riverside Partners Invests in Syner-G Pharma Consulting

October 29, 2020

Healthcare Services

Riverside Partners, a Boston-based private equity firm, completed an investment in Syner-G Pharma Consulting, a CMC regulatory and compliance consulting firm headquartered in Southborough, Massachusetts. The partnership with Syner-G's founders aims to support the company's next stage of growth, expand customer reach, and broaden service offerings to pharmaceutical and biotechnology clients.

Syner-G BioPharma Group (Riverside Partners) Acquires RMC Pharmaceutical Solutions

January 24, 2023

Healthcare Services

Syner-G BioPharma Group, a portfolio company of Riverside Partners, has acquired RMC Pharmaceutical Solutions, an outsourced CMC and quality management services provider based in Colorado. The add-on strengthens Syner-G's pharmaceutical science capabilities—particularly biologics and cell & gene therapy development—by integrating RMC's process and analytical development, regulatory strategy, and quality management expertise.

Riverside Partners Combines Sequoia Biotech Consulting and Syner-G BioPharma Group

September 18, 2024

Healthcare Services

Boston-based private equity firm Riverside Partners has combined two of its portfolio companies, Sequoia Biotech Consulting and Syner-G BioPharma Group, into a single, integrated life‑sciences services business. The combined organization — bringing together regulatory, development, quality, and operational capabilities — has approximately 500 employees and will provide end-to-end solutions to pharmaceutical, biotechnology, and medical device clients.

MedImpact Acquires Sav-Rx

February 2, 2026

Healthcare Services

MedImpact Healthcare Systems has completed the acquisition of Sav-Rx, a pharmacy benefit manager with more than five decades of experience serving organized labor. The deal expands MedImpact's scale, specialized PBM expertise, and health solutions portfolio while allowing Sav-Rx to operate independently under its existing leadership.

ProPharma Group Acquires Diamond Pharma Services

March 2, 2021

Healthcare Services

ProPharma Group, a portfolio company of Odyssey Investment Partners, has acquired Diamond Pharma Services, a UK-based regulatory affairs, pharmacovigilance, and compliance consultancy. The deal expands ProPharma's global regulatory and pharmacovigilance capabilities and adds Diamond's ~85+ experts and UK footprint to ProPharma's existing suite of services.

Symeres Acquires DGr Pharma

September 15, 2025

Healthcare Services

Symeres has acquired DGr Pharma to strengthen its early‑stage drug development and regulatory consultancy capabilities, accelerating IND‑enabling services for biopharma clients. The deal is supported by Keensight Capital, which backs Symeres and aims to expand the platform's integrated CRDMO offering across discovery and early clinical development.